| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |